T1297临床治疗方案在设计期间考虑的议题.pdfVIP

  • 0
  • 0
  • 约小于1千字
  • 约 3页
  • 2015-08-27 发布于安徽
  • 举报

T1297临床治疗方案在设计期间考虑的议题.pdf

IssuesconsideredatthedesigningstageoftheT1297clinicalprotocol Lung-AnLi ResearchFellow,InstituteofStatisticalScience,AcademiaSinica, Taipei,Taiwan11529 T1297isarandomizedphaseⅢ clinicaltrialofadjuvantinterferonalfa-2bin hepatocellularcarcinomawithcurativeresectionofTCOG(TaiwanCooperative OncologyGroup).Thisarticlereportsissuesconsideredbystatisticiansatthe designingstageofthisprotocol,whichusuallywillnotbementionedwhenpaper submittedtoclinicaljournals. ~ae~nslgntstorr modificationis zhes. T1297临床治疗方案在设计期间

文档评论(0)

1亿VIP精品文档

相关文档